ReviewAbdominal radiology (New York)2026
Photon-counting CT-enabled urolithiasis phenotyping: virtual non-iodine reconstructions, automated measurement, and spectral radiomics.
Review in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seeing the invisible: practical strategies to maximize the clinical impact of photon-counting CT in abdominal imaging.Abdominal radiology (New York) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewUrolithiasis management increasingly depends on accurate, noninvasive stone phenotyping to guide acute intervention, secondary prevention, and selective chemolitholysis. Photon-counting computed tomography (PCCT) introduces detector-level energy discrimination and higher spatial resolution, enabling calcium-preserving reconstruction strategies and quantitative spectral analytics that may shift stone characterization from a laboratory endpoint toward an imaging-derived biomarker. RECENT
findingsRecent peer-reviewed PCCT studies have concentrated on three translational domains. First, calcium-preserving virtual non-iodine (VNI) and virtual non-contrast (VNC) reconstructions have been evaluated for upper-tract stone detection in contrast-enhanced settings, supporting the concept that a single contrast-enhanced acquisition could potentially replace multiphase protocols in selected scenarios. Second, comparative ex vivo and clinical imaging studies suggest that PCCT improves depiction of small calculi and enables automated, high-resolution stone burden quantification. Third, spectral radiomics and machine-learning models have been applied to monoenergetic PCCT reconstructions for multi-class stone composition discrimination, achieving high discriminatory performance in controlled ex vivo datasets, and complementary phantom work has demonstrated automated uric acid versus non-uric acid classification. The emerging literature suggests that PCCT may support calcium-preserving assessment of stones in contrast-enhanced imaging, automated and reproducible stone burden quantification, and composition phenotyping via spectral analytics. However, most studies remain phantom/ex vivo and highly platform-specific. Translation will depend on prospectively defined acquisition and reconstruction parameters, externally validated models, and rigorous reporting aligned with contemporary machine-learning standards.
Indexed as
Identifiers
41817746What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.